Charles River Laboratories International Inc (NYSE: CRL) is 1.79% higher on its value in year-to-date trading and has touched a low of $176.48 and a high of $275.00 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CRL stock was last observed hovering at around $189.76 in the last trading session, with the day’s loss setting it -1.85%.
Currently trading at $187.91, the stock is 0.11% and -2.52% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.49 million and changing -0.97% at the moment leaves the stock -10.33% off its SMA200. CRL registered -17.19% loss for a year compared to 6-month loss of -7.30%. The firm has a 50-day simple moving average (SMA 50) of $192.7686 and a 200-day simple moving average (SMA200) of $209.55486.
The stock witnessed a -2.03% gain in the last 1 month and extending the period to 3 months gives it a 0.58%, and is 1.79% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.21% over the week and 2.99% over the month.
Charles River Laboratories International Inc (CRL) has around 21800 employees, a market worth around $9.61B and $4.06B in sales. Current P/E ratio is 23.20 and Fwd P/E is 18.28. Profit margin for the company is 10.31%. Distance from 52-week low is 6.48% and -31.67% from its 52-week high. The company has generated returns on investments over the last 12 months (6.40%).
The EPS is expected to shrink by -4.40% this year
910.0 institutions hold shares in Charles River Laboratories International Inc (CRL), with institutional investors hold 104.87% of the company’s shares. The shares outstanding are 51.13M, and float is at 50.59M with Short Float at 4.24%. Institutions hold 103.91% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 6.1 million shares valued at $1.26 billion. The investor’s holdings represent 11.8396 of the CRL Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 5.09 million shares valued at $1.05 billion to account for 9.8699 of the shares outstanding. The other top investors are STATE STREET CORP which holds 2.09 million shares representing 4.052 and valued at over $431.52 million, while KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC holds 3.7031 of the shares totaling 1.91 million with a market value of $394.36 million.
Charles River Laboratories International Inc (CRL) Insider Activity
The most recent transaction is an insider sale by WALLMAN RICHARD F, the company’s Director. SEC filings show that WALLMAN RICHARD F sold 6,621 shares of the company’s common stock on Nov 07 ’24 at a price of $216.12 per share for a total of $1.43 million. Following the sale, the insider now owns 12386.0 shares.
Charles River Laboratories International Inc disclosed in a document filed with the SEC on Nov 07 ’24 that WALLMAN RICHARD F (Director) sold a total of 1,000 shares of the company’s common stock. The trade occurred on Nov 07 ’24 and was made at $216.50 per share for $0.22 million. Following the transaction, the insider now directly holds 0.0 shares of the CRL stock.
Still, SEC filings show that on Nov 07 ’24, WALLMAN RICHARD F (Director) Proposed Sale 12,161 shares at an average price of $216.01 for $2.63 million. The insider now directly holds shares of Charles River Laboratories International Inc (CRL).
